Corcept Therapeutics | CORT - Interest Income


Corcept Therapeutics reported $5.58M in Interest Income for its fiscal quarter ending in September of 2026.





Interest Income Change Date
Acadia Pharmaceuticals USD 7.99M 65K Jun/2026
Aurora Cannabis CAD 1.24M 201K Jun/2026
BioMarin Pharmaceutical USD 4.63M 5.85M Sep/2026
Canopy Growth CAD 3.23M 630K Jun/2026
Corcept Therapeutics USD 5.58M 952K Sep/2026
Eli Lilly USD 65M 25M Sep/2025
J&J USD 0.09 2.18 Sep/2026
Knight Therapeutics CAD 2.46M 498K Sep/2024
Merck USD 35M 0 Jun/2026
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pacira USD 2.5M 551K Sep/2026
Pfizer USD 0.56 0.6 Sep/2026
Supernus Pharmaceuticals USD 2.63M 248K Jun/2026